Tjellström Bo, Högberg Lotta, Stenhammar Lars, Magnusson Karl-Eric, Midtvedt Tore, Norin Elisabeth, Sundqvist Tommy
Department of Microbiology, Karolinska Institute, Tumor and Cell Biology, Stockholm, Sweden.
Scand J Gastroenterol. 2012 Dec;47(12):1454-9. doi: 10.3109/00365521.2012.703234. Epub 2012 Sep 28.
Exclusive enteral nutrition (EEN) is a first-line treatment in children with active Crohn's disease (CD) but is seldom used in adults with active disease. The mode of action of EEN in suppressing mucosal inflammation is not fully understood, but modulation of intestinal microflora activity is one possible explanation. The aim of this study was to investigate the effect of 6-week EEN in children with active CD, with special reference to intestinal microflora function.
Fecal samples from 18 children (11 boys, 7 girls; median age 13.5 years) with active CD (13 children with small bowel/colonic and 5 with perianal disease) were analyzed for short chain fatty acid (SCFA) pattern as marker of gut microflora function. The children were studied before and after EEN treatment. Results from 12 healthy teenagers were used for comparison.
Eleven (79%) of the children with small bowel/colonic CD responded clinically positively to EEN treatment showing decreased levels of pro-inflammatory acetic acid as well as increased concentrations of anti-inflammatory butyric acids and also of valeric acids, similar to the levels in healthy age-matched children. In children with active perianal CD, however, EEN had no positive effect on clinical status or inflammatory parameters.
The authors present new data supporting the hypothesis that the well-documented anti-inflammatory effect of EEN in children with active small bowel/colonic CD is brought about by modulation of gut microflora activity, resulting in an anti-inflammatory SCFA pattern. By contrast, none of the children with perianal disease showed clinical or biochemical improvement after EEN treatment.
全肠内营养(EEN)是活动期克罗恩病(CD)患儿的一线治疗方法,但很少用于活动期成年患者。EEN抑制黏膜炎症的作用机制尚未完全明确,肠道微生物群活性的调节是一种可能的解释。本研究旨在探讨6周EEN对活动期CD患儿的影响,特别关注肠道微生物群功能。
分析18例活动期CD患儿(11例男孩,7例女孩;中位年龄13.5岁)(13例小肠/结肠型和5例肛周型疾病)的粪便样本,以短链脂肪酸(SCFA)模式作为肠道微生物群功能的标志物。在EEN治疗前后对这些患儿进行研究。使用12名健康青少年的结果进行比较。
11例(79%)小肠/结肠型CD患儿对EEN治疗有临床阳性反应,促炎乙酸水平降低,抗炎丁酸以及戊酸浓度增加,与年龄匹配的健康儿童水平相似。然而,对于活动期肛周CD患儿,EEN对临床状态或炎症参数没有积极影响。
作者提供了新的数据支持以下假设:EEN对活动期小肠/结肠型CD患儿具有充分记录的抗炎作用是通过调节肠道微生物群活性实现的,从而产生抗炎性SCFA模式。相比之下,肛周疾病患儿在EEN治疗后均未显示出临床或生化改善。